Optimization of a Mucoadhesive Vaginal Gel Containing Clotrimazole Using a D-Optimal Experimental Design and Multivariate Analysis.

FT-IR bioadhesion multivariate analysis polyacrylic acid polyethene oxides statistical optimization vaginal candidiasis

Journal

Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357

Informations de publication

Date de publication:
24 Apr 2023
Historique:
received: 31 03 2023
revised: 19 04 2023
accepted: 23 04 2023
medline: 13 5 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: epublish

Résumé

The aim of this study was to develop a suitable clotrimazole (CLT)-loaded mucoadhesive vaginal gel (CLT-MVG) for topical applications in vaginal candidiasis. Ten CLT-MVG formulations were prepared, consisting of mixtures of acid polyacrylic (Carbopol 940) and polyethene oxides, Sentry Polyox WSRN 1105 or 750, according to an experimental D-optimal design, and CLT was suspended at a ratio of 1%. The prepared CLT-MVG formulations were studied in vitro, and the formulation containing Carbopol 940 0.89% combined with PEO 1105 1.39% was identified with the optimal rheological and in vitro bioadhesion properties, ensuring the prolonged release of CLT, with a similarity factor greater than 50, indicating dissolution profile similarity for three batches of the optimized formulation. This optimized formulation showed a pH in the tolerance range, and an adequate ex vivo mucoadhesion time, while the FT-IR studies revealed no interactions between the excipients and CLT. The microscopic analysis identified a mean particle size of suspended CLT of 5.24 ± 0.57 μm. The in vitro antifungal activity of the optimized formulation was tested on twenty strains of

Identifiants

pubmed: 37177171
pii: polym15092023
doi: 10.3390/polym15092023
pmc: PMC10181139
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Curr Pharm Des. 2015;21(29):4285-309
pubmed: 26323422
Polymers (Basel). 2022 Nov 26;14(23):
pubmed: 36501540
Pharm Dev Technol. 2020 Dec;25(10):1238-1248
pubmed: 32787718
Pharm Dev Technol. 2017 Jun;22(4):551-561
pubmed: 27055376
Am J Obstet Gynecol. 2016 Jan;214(1):15-21
pubmed: 26164695
Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:886-893
pubmed: 28629093
Folia Med (Plovdiv). 2019 Jun 1;61(2):266-276
pubmed: 31301667
Pharmaceutics. 2021 Oct 15;13(10):
pubmed: 34683995
Curr Mol Pharmacol. 2021;14(3):281-291
pubmed: 32564767
Curr Infect Dis Rep. 2019 Nov 9;21(11):44
pubmed: 31707496
Int J Pharm. 2021 Nov 20;609:121182
pubmed: 34648879
Curr Infect Dis Rep. 2015 Jun;17(6):462
pubmed: 25916994
Adv Drug Deliv Rev. 2015 Sep 15;92:105-22
pubmed: 26144995
Eur J Pharm Biopharm. 2015 Oct;96:173-84
pubmed: 26235393
Menopause. 2016 Apr;23(4):368-75
pubmed: 26645820
Drug Deliv. 2021 Dec;28(1):814-825
pubmed: 33899634
Saudi Pharm J. 2019 Dec;27(8):1096-1106
pubmed: 31885469
Drug Deliv. 2016;23(2):550-63
pubmed: 24959937
Gels. 2021 Dec 12;7(4):
pubmed: 34940319
Int J Pharm Investig. 2016 Jan-Mar;6(1):47-55
pubmed: 27014619
Clin Infect Dis. 2019 May 17;68(11):1791-1797
pubmed: 30204844
ScientificWorldJournal. 2014 Mar 24;2014:280928
pubmed: 24790559
Curr Drug Deliv. 2009 Jan;6(1):83-92
pubmed: 19418960
Lancet Infect Dis. 2018 Nov;18(11):e339-e347
pubmed: 30078662
Pharmaceutics. 2021 Jun 15;13(6):
pubmed: 34203714
Eur J Pharm Sci. 2018 Jan 1;111:358-375
pubmed: 28986195
Molecules. 2019 Jul 12;24(14):
pubmed: 31336916
Molecules. 2020 Mar 27;25(7):
pubmed: 32230990
Pharmaceutics. 2023 Feb 08;15(2):
pubmed: 36839899

Auteurs

Elena Dinte (E)

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Rares Iuliu Iovanov (RI)

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Andreea Elena Bodoki (AE)

Department of General and Inorganic Chemistry, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 400010 Cluj-Napoca, Romania.

Ioana Alina Colosi (IA)

Department of Microbiology, Iuliu Hatieganu, Faculty of Medicine, University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Horatiu Alexandru Colosi (HA)

Department of Medical Education, Division of Medical Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Nicoleta Tosa (N)

Molecular and Biomolecular Department, National Institute for Research & Development of Isotopic and Molecular Technologies, 400293 Cluj-Napoca, Romania.

Oliviu Vostinaru (O)

Department of Pharmacology, Physiology and Physiopathology, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Ioan Tomuta (I)

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Classifications MeSH